When the Dutch government liberalised cannabis policy in 1976, they understood that the legalisation and regulation of cannabis was actually the best solution, or at least the least bad one.
The recent report ‘The Netherlands and Synthetic Drugs: An Inconvenient Truth’ argues for increasing resources to expand anti-drug efforts in the Netherlands. In a topical opinion piece, Tom Blickman addresses the crucial issues at hand.
David Bewley-Taylor, Tom Blickman, Martin Jelsma, John Walsh
03 ဧပြီလ 2018
Opinion
Ever since the introduction of Bill C-45, questions have been swirling concerning Canada’s position relative to the UN drug control conventions: conventions to which Canada is a party and that, crucially, prohibit the creation of regulated markets for the recreational use of cannabis.
These are interesting times for drug law reform, which, as it gathers pace, is asking important questions of international law. A UN General Assembly Special Session on Drugs is set for 2016 just as national reforms are challenging international treaties that form the bedrock of a global prohibition regime that has dominated since the turn of the twentieth century. States parties to the three UN drug control conventions must now confront the legal and political dilemmas this creates. This is the situation in which the US now finds itself following cannabis reforms in various states that are at odds with these treaties.
UN’s International Narcotics Control Board (INCB) unprecedented condemnation of the use of death penalty for drug-related offences is welcome if long overdue. The bigger question is whether INCB’s consideration of human rights can be extended into a proper human rights and evidence-based examination of UN’s entire drug control regime.